Pharmaceutical wholesaler United Drug said today that it had seen a good first quarter with more independent pharmacists continuing to move their business to the company.
The company also announced today that its Chairman Martin Rafferty is to retire in September. He will be succeeded by Ronnie Kells, who is a director of Readymix and a former CEO of Ulster bank.
Rafferty said today he was confident that the company will have another successful year and that organic growth will continue with more bolt on acquisitions.
He reiterated that the company will not be branching out into retail like some of its major competitors.
Shares in United Drug were up 10 cent at €3.70 this lunchtime on the ISEQ.
